AI-driven company anumana partnered with Novartis to drive the development of its electrocardiogram (ECG) AI algorithms to detect subclinical heart disease.
The two generic drugs have been launched under the brand names Jankey & Sitenali.
Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery
First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage and freedom from clinically-driven target lesion revascularization
Approval based on groundbreaking Phase 3 EXPLORER-HCM trial demonstrating benefit in patients receiving Camzyos versus placebo
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
The initiative brings internationally eminent cardiologists to increase awareness of health screening tests amongst pre-menopausal women
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
This unique record was made possible by collating hard copies of the books in a structured manner
Ultreon 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using AI -
Subscribe To Our Newsletter & Stay Updated
